Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chéron

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|June 15, 1981
[Incorporation of (3R,3'R)zeaxanthin in vesicles of dipalmitoyl phosphatidylcholine. Circular dichroism analysis]M Chéron, J Bolard
FEBS Letters|December 3, 1984
Inhibition by Cu2+ of amphotericin B induced lysis of erythrocytesM Chéron, J Bolard, J Brajtburg
Antimicrobial Agents and Chemotherapy|November 26, 1997
Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic indexF Gaboriau, M Chéron, C Petit, et al.
Journal of Drug Targeting|January 1, 1997
Release of amphotericin B from delivery systems and its action against fungal and mammalian cellsP Legrand, M Chéron, L Leroy, et al.
Biophysical Chemistry|May 21, 1997
Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin BF Gaboriau, M Chéron, L Leroy, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 26, 1975
[Alpha-mannosidase activity of different human biological fluids]J M Chéron, P Rahimulla, J E Courtois, et al.
Biochemical Pharmacology|March 1, 1988
Quantitative structure-activity relationships in amphotericin B derivativesM Chéron, B Cybulska, J Mazerski, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 10, 2011
[Identifying addictive behaviors among adolescents: a school-based survey]M Chéron-Launay, M Baha, C Mautrait, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heatingC Petit, M Chéron, V Joly, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidV Joly, R Farinotti, L Saint-Julien, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|June 15, 1981
[Incorporation of (3R,3'R)zeaxanthin in vesicles of dipalmitoyl phosphatidylcholine. Circular dichroism analysis]M Chéron, J Bolard
FEBS Letters|December 3, 1984
Inhibition by Cu2+ of amphotericin B induced lysis of erythrocytesM Chéron, J Bolard, J Brajtburg
Antimicrobial Agents and Chemotherapy|November 26, 1997
Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic indexF Gaboriau, M Chéron, C Petit, et al.
Journal of Drug Targeting|January 1, 1997
Release of amphotericin B from delivery systems and its action against fungal and mammalian cellsP Legrand, M Chéron, L Leroy, et al.
Biophysical Chemistry|May 21, 1997
Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin BF Gaboriau, M Chéron, L Leroy, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 26, 1975
[Alpha-mannosidase activity of different human biological fluids]J M Chéron, P Rahimulla, J E Courtois, et al.
Biochemical Pharmacology|March 1, 1988
Quantitative structure-activity relationships in amphotericin B derivativesM Chéron, B Cybulska, J Mazerski, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 10, 2011
[Identifying addictive behaviors among adolescents: a school-based survey]M Chéron-Launay, M Baha, C Mautrait, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heatingC Petit, M Chéron, V Joly, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidV Joly, R Farinotti, L Saint-Julien, et al.
Pageof 2